Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINHALATIONStandard

DESFLURANE

DESFLURANE

Standard Dose
100%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview DESFLURANE is listed in Drugs@FDA under application 208234 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient DESFLURANE Form and strength LIQUID;INHALATION - 100% Sponsor SHANGHAI HENGRUI Submission history Latest submission status date: 2024-11-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview DESFLURANE is listed in Drugs@FDA under application 208234 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient DESFLURANE Form and strength LIQUID;INHALATION - 100% Sponsor SHANGHAI HENGRUI Submission history Latest submission status date: 2024-11-07 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.